Industry

DUBLIN–(BUSINESS WIRE)–The “Europe Alcohol Dependence Market and Competitive Landscape – 2021” report has been added to ResearchAndMarkets.com’s offering. The research provides comprehensive insights into Alcohol Dependence pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts Alcohol Dependence market size and drug sales. It also provides insights … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Europe Erectile Dysfunction Market and Competitive Landscape – 2021” report has been added to ResearchAndMarkets.com’s offering. The research provides comprehensive insights into Erectile Dysfunction pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts Erectile Dysfunction market size and drug sales. It also provides insights … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Europe Cystic Fibrosis Market and Competitive Landscape – 2021” report has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive insights into Cystic Fibrosis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts Cystic Fibrosis market size and drug sales. It also provides insights … [Read more…]

Next-generation RNA technology can be safer, more effective at lower doses than current mRNA COVID-19 vaccines Proprietary LIONTM delivery system provides stability at refrigerator temperature SEATTLE–(BUSINESS WIRE)–Indian regulators have issued an Emergency Use Approval for Gemcovac, a groundbreaking COVID-19 vaccine based on the technology of Seattle biotech HDT Bio Corp. The vaccine uses self-amplifying RNA … [Read more…]

ATLANTA–(BUSINESS WIRE)–Azalea Health, a leading provider of fully-integrated cloud-based healthcare IT solutions and services, announced today Julieann Esper Rainville has joined its board of directors. Rainville is the president of PointClickCare, a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights. She was recently ranked number one among The Top 25 Women … [Read more…]

STONY BROOK, N.Y.–(BUSINESS WIRE)–$APDN #LinearDNA—Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in cell-free, enzymatic DNA production, announced the formal launch of business development initiatives to expand the biotherapeutics industry’s awareness of the LinearDNA™ platform (the “platform”) as an alternative to current plasmid-based (pDNA) production processes used in the manufacture of DNA for … [Read more…]

GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, today announced new clinical outcomes data and scientific research, showcasing the power behind the company’s platform of Active Intelligence® technologies. The studies were presented at the 2022 International Society for Computer Assisted Orthopaedic Surgery (CAOS) annual meeting. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Neutrophil Elastase Inhibitor – Pipeline Insight, 2022” clinical trials has been added to ResearchAndMarkets.com’s offering. “Neutrophil Elastase Inhibitor – Pipeline Insight, 2022” report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Neutrophil Elastase Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “US Biosensors Market (2022-2027) by Type, Product, Application, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The US Biosensors Market is estimated to be USD 6.49 Bn in 2022 and is projected to reach USD 11.22 Bn by 2027, growing at a CAGR of … [Read more…]

SAN CLEMENTE, Calif.–(BUSINESS WIRE)–#CLIFighters—Reflow Medical, Inc., a California-based medical device company, has completed enrollment in the DEEPER LIMUS clinical trial (NCT04162418) to evaluate the Temporary Spur Stent System, a patented device designed to treat long, diffuse and severely calcified infrapopliteal disease. The system allows for uniform expansion of the stent to maximize lumen diameter and … [Read more…]